Search Results

By Susan Reckling  / Tuesday, July 8, 2014 2:42 PM

Preclinical Study Reveals Heparan Sulfate Suppresses Growth of Neuroblastoma

A heparin derivative differentiated cancer cells and caused neuroblastomas to regress without causing severe bleeding, according to the findings of a preclinical study presented in The Journal of Clinical Investigation. Knelson et al identified novel roles for heparan sulfate proteoglycans in...